Old Web
English
Sign In
Acemap
>
authorDetail
>
Paul L. Domanico
Paul L. Domanico
Pharmacology
Prodrug
Bioavailability
Pharmacokinetics
Dolutegravir
3
Papers
67
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The transition to dolutegravir and other new antiretrovirals in low-income and middle-income countries: What are the issues?
2018
AIDS
Marco Vitoria
Andrew Hill
Nathan Ford
Meg Caroline Doherty
Polly Clayden
Francois Venter
David Ripin
Charles Williams Flexner
Paul L. Domanico
Show All
Source
Cite
Save
Citations (57)
Simulating Intestinal Transporter and Enzyme Activity in a Physiologically Based Pharmacokinetic Model for Tenofovir Disoproxil Fumarate
2017
Antimicrobial Agents and Chemotherapy
Darren M. Moss
Paul L. Domanico
Melynda Watkins
Seonghee Park
Ryan Randolph
Steve Wring
Rajith Kumar Reddy Rajoli
James J. Hobson
Steve P. Rannard
Marco Siccardi
Andrew Owen
Show All
Source
Cite
Save
Citations (4)
Development of a Novel Formulation That Improves Preclinical Bioavailability of Tenofovir Disoproxil Fumarate
2017
Journal of Pharmaceutical Sciences
Melynda Watkins
Steve Wring
Ryan Randolph
Seonghee Park
Kendall Powell
Lissa Lutz
Michelle Nowakowski
Ram Ramabhadran
Paul L. Domanico
Show All
Source
Cite
Save
Citations (6)
1